Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC

Clinical trial NCT05721443 · COMPLETED

Trial details

NCT number: NCT05721443
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Start date: 2022-12-01
Primary completion: 2024-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.